18F-氟化钠与18F-氟脱氧葡萄糖PET评估钙化斑块进展中成骨与炎症的关联
34例骨髓瘤患者接受18F-NaF与18F-FDG PET/CT,按钙密度分非钙化、轻度钙化、重度钙化病灶。基线221个病灶两示踪剂最大组织本底比相关(Spearman r=0.5,P<0.01;Pearson r=0.4,P<0.01);非钙化病灶摄取最高但两示踪剂无相关;随访19例见钙密度与平均18F-NaF摄取升高、平均18F-FDG摄取降低。
要点
- 基线221个病灶中两示踪剂最大组织本底比呈显著相关(Spearman r=0.5,P<0.01;Pearson r=0.4,P<0.01)。
- 非钙化病灶两示踪剂摄取最高,但二者无相关(Pearson r=0.06,P=0.76)。
- 随访见钙密度与平均18F-NaF摄取升高,平均18F-FDG摄取降低。
核心结论
- 18F-NaF PET与18F-FDG PET联合成像有助于理解斑块进展机制,为斑块稳定提供新见解。
研究设计与样本
- 34例骨髓瘤患者接受18F-NaF与18F-FDG PET/CT检查。
- 按CT测得的Hounsfield单位钙密度将病灶分为非钙化、轻度钙化、重度钙化3组。
- 对两种示踪剂分别测定组织本底比。
- 在19例至少接受2次两种示踪剂检查的患者中评估动脉粥样硬化进展过程中炎症与成骨的关联。
主要发现
- 基线221个病灶中两示踪剂最大组织本底比显著相关(Spearman r=0.5,P<0.01;Pearson r=0.4,P<0.01)。
- 非钙化病灶两示踪剂摄取最高,但二者无相关(Pearson r=0.06,P=0.76)。
- 与未钙化斑块相比,轻度钙化斑块两示踪剂蓄积一致显著降低,且二者相关性良好(Pearson r=0.7,P<0.01)。
- 重度钙化病灶中观察到成骨来源的18F-NaF摄取增强与炎症消退来源的18F-FDG摄取(Pearson r=0.4,P<0.01)。
- 随访期间钙密度与平均18F-NaF摄取升高,而平均18F-FDG摄取降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
18F-FDG is the most widely validated PET tracer for the evaluation of atherosclerotic inflammation. Recently, 18F-NaF has also been considered a potential novel biomarker of osteogenesis in atherosclerosis. We aimed to analyze the association between inflammation and osteogenesis at different stages of atherosclerosis, as well as the interrelationship between these 2 processes during disease progression. Methods: Thirty-four myeloma patients underwent 18F-NaF and 18F-FDG PET/CT examinations. Lesions were divided into 3 groups (noncalcified, mildly calcified, and severely calcified lesions) on the basis of calcium density as measured in Hounsfield units by CT. Tissue-to-background ratios were determined from PET for both tracers. The association between inflammation and osteogenesis during atherosclerosis progression was evaluated in 19 patients who had at least 2 examinations with both tracers. Results: There were significant correlations between the maximum tissue-to-background ratios of the 2 tracers (Spearman r = 0.5 [P < 0.01]; Pearson r = 0.4 [P < 0.01]) in the 221 lesions at baseline. The highest uptake of both tracers was observed in noncalcified lesions, but without any correlation between the tracers (Pearson r = 0.06; P = 0.76). Compared with noncalcified plaques, mildly calcified plaques showed concordant significantly lower accumulation, with good correlation between the tracers (Pearson r = 0.7; P < 0.01). In addition, enhanced osteogenesis-derived 18F-NaF uptake and regressive inflammation-derived 18F-FDG uptake were observed in severely calcified lesions (Pearson r = 0.4; P < 0.01). During follow-up, increased calcium density and increased mean 18F-NaF uptake were observed, whereas mean 18F-FDG uptake decreased. Most noncalcified (86%) and mildly calcified (81%) lesions and 47% of severely calcified lesions had concordant development of both vascular inflammation and osteogenesis. Conclusion: The combination of 18F-NaF PET imaging and 18F-FDG PET imaging promotes an understanding of the mechanism of plaque progression, thereby providing new insights into plaque stabilization.
引用
- Li X, Heber D, Cal-Gonzalez J, et al. Association Between Osteogenesis and Inflammation During the Progression of Calcified Plaque Evaluated by 18F-Fluoride and 18F-FDG. J Nucl Med. 2017. PMID: 28232606. doi:10.2967/jnumed.116.182790
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。